Active Clearance of Chest Tubes After Cardiac Surgery: A Prospective Randomized Controlled Study (NCT02808897) | Clinical Trial Compass
CompletedNot Applicable
Active Clearance of Chest Tubes After Cardiac Surgery: A Prospective Randomized Controlled Study
Canada520 participantsStarted 2015-11
Plain-language summary
The purpose of this study is to assess the effectiveness of the PleuraFlow® Active Tube Clearance (ATC) technology in reducing the rate of postoperative atrial fibrillation (POAF) among post cardiac surgery patients and to evaluate the impact of Active Tube Clearance (ATC) on other complications, such as retained blood syndrome (RBS), a composite endpoint including re-exploration for bleeding or tamponade, and interventions for hemothorax, pericardial or pleural effusion.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Admission for coronary artery bypass graft (CABG), valve replacement or valve repair surgery, or a combination of these surgeries;
✓. Surgical procedure(s) on the ascending aorta and/or aortic arch that do not require deep hypothermic arrest (deep hypothermic arrest is defined as \< 18° C);
✓. Must be in sinus rhythm (SR) for a minimum of 30 days prior to the index surgery and at the start of the index surgery. No patient with history of atrial fibrillation.
✓. Sign the institutional review board/institutional ethics committee approved informed consent form after the nature of the study has been explained and questions/concern have been addressed.
Exclusion criteria
✕. Admitted for surgical treatment of arrhythmia or Atrial fibrillation history;
✕. Admitted for cardiac surgery requiring implantation/explantation of a Ventricular Assist Device (VAD) or heart transplant;
✕. Admitted for Transcatheter aortic valve replacement (TAVR);
✕. Cardiac surgical procedure that requires deep hypothermic arrest (as defined above);
✕. New or active endocarditis or myocarditis that is not adequately controlled with medication and/or requires surgical intervention;
✕. Documented inherited bleeding disorder(s);or
✕. History or known allergies to the device materials.
What they're measuring
1
Number of Participants With Postoperative Atrial Fibrillation
Timeframe: From post index surgery through hospital discharge, an average of 30 days